Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

Market Cap	3.68B +5.4%
Revenue (ttm)	1.34B +1.9%
Net Income	152.02M +2.4%
EPS	1.12 +2.8%
Shares Out	135.44M
PE Ratio	24.23
Forward PE	n/a
Dividend	0.40 (1.48%)
Ex-Dividend Date	Jun 13, 2025

Volume	1,340,260
Average Volume	1,157,174
Open	27.21
Previous Close	27.03
Day's Range	26.75 - 27.41
52-Week Range	23.24 - 33.34
Beta	0.17
RSI	61.33
Earnings Date	Apr 28, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material techno...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 711
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603351

Financial Performance

In 2025, SHA:603351's revenue was 1.34 billion, an increase of 2.95% compared to the previous year's 1.30 billion. Earnings were 150.97 million, an increase of 3.11%.